[go: up one dir, main page]

BE901667A - Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation. - Google Patents

Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.

Info

Publication number
BE901667A
BE901667A BE0/214461A BE214461A BE901667A BE 901667 A BE901667 A BE 901667A BE 0/214461 A BE0/214461 A BE 0/214461A BE 214461 A BE214461 A BE 214461A BE 901667 A BE901667 A BE 901667A
Authority
BE
Belgium
Prior art keywords
analgesic
diphenhydramine
preparation
composition based
inflammatory composition
Prior art date
Application number
BE0/214461A
Other languages
English (en)
Inventor
A Sunshine
E M Laska
C E Siegel
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of BE901667A publication Critical patent/BE901667A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composition pharmaceutiques comprenant des médicaments analgésiques/anti-inflammatoires non stéroidiques et de la diphénhydramine et procédé d'utilisation de ces compositions pour donner une réponse analgésique et/ou anti-inflammatoire accrue chez un mammifère ou un etre humain nécessitant un tel traitement.
BE0/214461A 1984-02-08 1985-02-06 Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation. BE901667A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/578,288 US4522826A (en) 1984-02-08 1984-02-08 Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same

Publications (1)

Publication Number Publication Date
BE901667A true BE901667A (fr) 1985-05-29

Family

ID=24312214

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214461A BE901667A (fr) 1984-02-08 1985-02-06 Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.

Country Status (14)

Country Link
US (1) US4522826A (fr)
JP (1) JPH0733331B2 (fr)
AT (1) AT390878B (fr)
AU (1) AU576825B2 (fr)
BE (1) BE901667A (fr)
CA (1) CA1251137A (fr)
CH (1) CH667392A5 (fr)
DE (2) DE3590035T1 (fr)
FR (1) FR2559061B1 (fr)
GB (1) GB2162747B (fr)
IT (1) IT1186181B (fr)
NL (1) NL193630C (fr)
WO (1) WO1985003443A1 (fr)
ZA (1) ZA85840B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
AU643187B2 (en) * 1984-04-09 1993-11-11 Eugene M. Laska Cough-cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
WO1986003681A1 (fr) * 1984-12-26 1986-07-03 Abraham Sunshine Produit a base d'analgesiques, d'anti-inflammatoires et de decontractants musculaires transosseux
JPH01197444A (ja) * 1986-03-04 1989-08-09 Bristol Myers Co 非ステロイド系抗炎症組成物によって生じる消化管損傷に対するβ−アドレナリン作用薬とある種のヒスタミンＨ↓１−および／またはＨ↓２−受容体遮断薬との組合せの効果
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
CH669523A5 (fr) * 1986-06-25 1989-03-31 Mepha Ag
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
EP0320550A1 (fr) * 1987-12-18 1989-06-21 Bristol-Myers Company Composition NSAID contenant des bloqueurs H1, bloqueurs H2, agonistes bêta-adrénergiques ou leurs mélanges et un agent alcalinisant
EP0321613A1 (fr) * 1987-12-18 1989-06-28 Bristol-Myers Company L'effet d'un mélange d'un agoniste bêta-adrénergique et de certains bloqueurs de récepteurs d'histamine H1et/ou H2 sur les lésions gastro-intestinales produites par des compositions de NSAID
US5071842A (en) * 1988-10-14 1991-12-10 Bristol-Myers Squibb Company Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
WO1992004021A1 (fr) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Procede permettant d'ameliorer l'effet analgesique
US5175152A (en) * 1990-09-28 1992-12-29 Singh Nikhilesh N Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
JPH06506198A (ja) * 1991-03-04 1994-07-14 ワーナー−ランバート・コンパニー 種々な剤形の非ステロイド性抗炎症剤の新規な塩／イオン対
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
AU4325697A (en) * 1997-06-23 1999-01-04 Mcneil-Ppc, Inc. Ibuprofen and diphenhydramine analgesics
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US20020177626A1 (en) * 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
ES2348710T5 (es) 2001-06-01 2014-02-17 Pozen, Inc. Composiciones farmacéuticas para el suministro coordinado de NSAID
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
JP5211677B2 (ja) * 2007-12-19 2013-06-12 ゼリア新薬工業株式会社 内服液剤
US20090214648A1 (en) * 2008-02-15 2009-08-27 Malathi Kandakatla Pharmaceutical formulations comprising ibuprofen and diphenhydramine
WO2010029335A1 (fr) 2008-09-09 2010-03-18 Astrazeneca Uk Limited Procédé d'administration d'une composition pharmaceutique à un patient en ayant besoin
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT194061B (de) * 1955-11-17 1957-12-27 Schering Ag Verfahren zur Herstellung geschmackfreier Zubereitungen basischer Antihistaminika
GB915813A (en) * 1959-12-31 1963-01-16 Biorex Laboratories Ltd Anti-anaphylactic compositions comprising alkanolamines and derivatives thereof
GR71929B (fr) * 1979-11-13 1983-08-19 Ici Ltd
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
EP0194547A2 (fr) * 1985-03-15 1986-09-17 Miles Laboratories, Inc. Composition effervescente stable d'acide acétylsalicylique et de citrate de diphenhydramine

Also Published As

Publication number Publication date
JPS61501393A (ja) 1986-07-10
ZA85840B (en) 1985-09-25
CH667392A5 (de) 1988-10-14
CA1251137A (fr) 1989-03-14
NL8520027A (nl) 1986-01-02
DE3590035T1 (de) 1986-03-13
IT8519382A0 (it) 1985-02-05
US4522826A (en) 1985-06-11
DE3590035C2 (de) 1998-07-09
NL193630B (fr) 2000-01-03
NL193630C (nl) 2000-05-04
FR2559061A1 (fr) 1985-08-09
GB2162747A (en) 1986-02-12
AU3935685A (en) 1985-08-27
AT390878B (de) 1990-07-10
ATA900385A (de) 1990-01-15
WO1985003443A1 (fr) 1985-08-15
GB2162747B (en) 1987-10-21
IT1186181B (it) 1987-11-18
JPH0733331B2 (ja) 1995-04-12
FR2559061B1 (fr) 1988-04-15
GB8521793D0 (en) 1985-10-09
AU576825B2 (en) 1988-09-08

Similar Documents

Publication Publication Date Title
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
FR2622798B1 (fr) Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
DZ2186A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'ostéoporose et procédé pour leur préparation.
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
EP0888054A4 (fr) Compositions d'apport de medicaments cible sur un site specifique et procede d'utilisation
CA2165520A1 (fr) Utilisation d'un antagoniste de substance p dans une composition pharmaceutique
PT101444A (pt) Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao
FR2628973B1 (fr) Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition
BE881208A (fr) Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci
CA2235038A1 (fr) Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
FR2453648A1 (fr) Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique
MA26522A1 (fr) Composition pharmaceutique pour le traitement du diabete sucre et d'etats associes.
FR2391202A1 (fr) Triazines-1,2,4 substituees, actives pharmacologiquement et medicaments contenant ces triazines
CA2165519A1 (fr) Utilisation d'un antagoniste de substance p pour le traitement des prurits, des algies oculaires et/ou palpebrales et des dysesthesies oculaires ou palpebrales
IT8423896A0 (it) Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT7920398A0 (it) Derivato ad attivita' analgesica antiinfiammatoria potenziata eprocedimento per la sua preparazione.
BE894597A (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques les contenant et leur utilisation en medecine humaine
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *RICHARDSON-VICKS INC.

Effective date: 20050206

RE20 Patent expired

Owner name: *RICHARDSON-VICKS INC.

Effective date: 20050206